Selecting an Accessory Device with a Metered-Dose Inhaler: Variable Influence of Accessory Devices on Fine Particle Dose, Throat Deposition, and Drug Delivery with Asynchronous Actuation from a Metered-Dose Inhaler
Authors:
- James FinkJFJames Fink
- Rajiv DhandRDRajiv Dhand
- 1 September 2001
- journal article
- research article
- Published by SAGE Publications in Journal of Aerosol Medicine
- Vol. 14 (3) , 351-360
Abstract
Accessory devices reduce common problems with metered-dose inhalers (MDIs), namely high oropharyngeal deposition of aerosol and incoordination between actuation and inhalation by the patient. The objective of this study was to systematically compare the performance of various accessory devices in vitro. MDIs were tested alone or in combination with four spacers (Toilet paper roll, Ellipse, Optihaler, Myst Assist) and five holding chambers (Aerochamber, Optichamber, Aerosol Cloud Enhancer, Medispacer, and Inspirease). An Anderson cascade impactor was used to measure aerosol mass median aerodynamic diameter (MMAD) and fine particle dose (MMAD < 4.7 μm). In separate experiments, the influence of asynchronous MDI actuation on drug delivery was determined with a simulated spontaneous breathing model. Compared with the MDI alone, all of the accessory devices reduced aerosol MMAD and increased lung-throat ratio (fine particle dose/throat impaction; p < 0.05 for both parameters). The fine particle dose of albuterol was 40% higher with the Ellipse (p < 0.01), was equivalent with the Toilet Paper Roll, Aerochamber, Optichamber, and Medispacer, and was 33-56% lower with the Optihaler, Myst Assist, Aerosol Cloud Enhancer, and Inspirease (p < 0.03). MDI actuation in synchrony with inspiration produced highest drug delivery; when MDI actuation occurred 1-sec before inspiration or during exhalation, decrease in drug delivery with holding chambers (10-40% reduction) was less than that with spacers (40-90% reduction). Accessory device selection is complicated by variability in performance between devices, and in the performance of each device in different clinical settings. In vitro characterization of a MDI and accessory device could guide appropriate device selection in various clinical settings.Keywords
This publication has 17 references indexed in Scilit:
- Particle Size Measurements for the Space-Chamber Metered Dose Inhaler Holding Chamber Compared with Aerochamber and Metered Dose Inhaler AloneJournal of Aerosol Medicine, 1997
- Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants.Thorax, 1996
- Inhalational drug delivery from seven different spacer devices.Thorax, 1996
- Comparative study of dose delivery and cascade impaction performance of four metered-dose inhaler and spacer combinationsCurrent Therapeutic Research, 1996
- Choosing the metered-dose inhaler spacer or holding chamber that matches the patient's need: Evidence that the specific drug being delivered is an important considerationJournal of Allergy and Clinical Immunology, 1995
- The optimal particle size for β-adrenergic aerosols in mild asthmaticsInternational Journal of Pharmaceutics, 1994
- Design and characteristics of a portable breath actuated, particle size selective medical aerosol inhalerJournal of Aerosol Science, 1982
- Candidiasis and dysphonia complicating beclomethasone treatment of asthmaJournal of Allergy and Clinical Immunology, 1980
- Patient error in use of bronchidilator metered aerosols.BMJ, 1976
- The association of syphilis with cirrhosis: the role of alcohol and serum hepatitisPostgraduate Medical Journal, 1975